Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort
- PMID: 29533997
- PMCID: PMC5867583
- DOI: 10.3390/jcm7030057
Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort
Abstract
Objectives: There is little information on the relation between disease duration, disability and radiographic outcome since the introduction of biologics into the therapy of rheumatoid arthritis (RA). No long -term cohort studies have been conducted on this subject so far. To analyse radiographic damage, disability, and disease activity in RA-patients dependent on disease duration in the Swiss national RA cohort (SCQM).
Methods: The primary outcome was the association between the radiographic destruction, assessed by Ratingen scores, and disease duration. All patients with at least one clinical visit were analysed with polynomial and multiple negative binomial models.
Results: The disease duration in the 8678 patients with available radiographs analysed ranged between less than 1 and more than 65 years (median 8.3). Disease duration and radiographic destruction were significantly associated with an average increase of Ratingen scores by 8.3% per year. Apart from disease duration, positive rheumatoid factor was the strongest predictor for radiographic destruction. While DAS28-scores remained stable in patients with a disease duration of more than 5 years (median DAS28 2.8), HAQ-DI scores increased continuously by 0.018 for each additional year.
Conclusion: In this RA cohort, patients show a continuous increase of articular destruction and physical disability in parallel with disease duration. Even when nowadays a satisfactory control of disease activity can be achieved in most patients, RA remains a destructive disease leading to joint destruction and physical disability in many patients.
Keywords: ACPA; DAS28; HAQ-DI; Ratingen score; disease duration; radiographic destruction; rheumatoid arthritis; rheumatoid factor.
Conflict of interest statement
The authors have nothing to disclose that directly or indirectly might affect, or be perceived to affect, the conduct or reporting of the work they have submitted.
Figures




Similar articles
-
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort.Rheumatology (Oxford). 2014 Apr;53(4):671-7. doi: 10.1093/rheumatology/ket399. Epub 2013 Dec 17. Rheumatology (Oxford). 2014. PMID: 24352338
-
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).Clin Rheumatol. 2017 Jan;36(1):59-66. doi: 10.1007/s10067-016-3468-6. Epub 2016 Nov 12. Clin Rheumatol. 2017. PMID: 27838788
-
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?J Rheumatol. 2014 Aug;41(8):1576-82. doi: 10.3899/jrheum.130767. Epub 2014 Jul 15. J Rheumatol. 2014. PMID: 25028383
-
Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.J Rheumatol. 2013 Sep;40(9):1505-12. doi: 10.3899/jrheum.121346. Epub 2013 Jul 1. J Rheumatol. 2013. PMID: 23818710 Clinical Trial.
-
Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high with worsening of patient-related outcomes.Clin Exp Rheumatol. 2022 Mar;40(3):589-595. doi: 10.55563/clinexprheumatol/jpysud. Epub 2021 May 5. Clin Exp Rheumatol. 2022. PMID: 34001300
Cited by
-
Does the Change of Weather Influence Disease Activity in Rheumatoid Arthritis Patients: Patients' Self-Assessment via WebApp.J Clin Med. 2024 Sep 9;13(17):5336. doi: 10.3390/jcm13175336. J Clin Med. 2024. PMID: 39274548 Free PMC article.
-
How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target Strategy.J Clin Med. 2019 Apr 15;8(4):515. doi: 10.3390/jcm8040515. J Clin Med. 2019. PMID: 30991730 Free PMC article.
-
Association of multimorbidity patterns with incident disability and recovery of independence among middle-aged and older adults.Age Ageing. 2022 Aug 2;51(8):afac177. doi: 10.1093/ageing/afac177. Age Ageing. 2022. PMID: 35930720 Free PMC article.
-
Cost-utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations.Scand J Rheumatol. 2025 Mar;54(2):87-97. doi: 10.1080/03009742.2024.2392360. Epub 2024 Oct 1. Scand J Rheumatol. 2025. PMID: 39351606 Free PMC article. Clinical Trial.
-
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).Clin Rheumatol. 2022 Apr;41(4):1045-1055. doi: 10.1007/s10067-021-05908-z. Epub 2022 Jan 1. Clin Rheumatol. 2022. PMID: 34973077 Free PMC article. Clinical Trial.
References
-
- Wolfe F., Hawley D.J. The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients. J. Rheumatol. 1998;25:2108–2117. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources